Sign Up Today and Learn More About Miromatrix Medical Stock

Invest in or calculate the value of your shares in Miromatrix Medical or other pre-IPO companies through EquityZen's platform.

Get Started

Miromatrix Medical Stock

Biological human organ development

About Miromatrix Medical Stock

Founded

2008

Headquarters

Eden Prairie, MN, US

Notable Investor

National Institute of Diabetes and Digestive and Kidney Diseases

Total Funding

57.5M

Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care. The company was founded in 2009 and is based in Eden Prairie, Minnesota.

Investors in Miromatrix Medical

Discover investors in Miromatrix Medical stock and explore their portfolio companies

Miromatrix Medical Management

Leadership team at Miromatrix Medical

President and CEO

Jeff Ross, Ph.D

Vice-President of Research and Development

Thomas Gilbert, Ph.D

Locked Features

Join now and verify your accreditation status to gain access to:

  • Miromatrix Medical current valuation
  • Miromatrix Medical stock price
  • Available deals in Miromatrix Medical and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Miromatrix Medical stock?

Accredited investors can buy pre-IPO stock in companies like Miromatrix Medical through EquityZen funds. These investments are made available by existing Miromatrix Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Miromatrix Medical stock?

Shareholders can sell their Miromatrix Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."